ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 122

Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children

Chelsea Reynolds1, Natasha Ruth2 and Joyce Chang3, 1MUSC, 2Medical University South Carolina, Charleston, SC, 3Boston Children's Hospital, Newton, MA

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Posters: Quality, Health Services, and Education Research II

Session Time: 5:00PM-6:00PM

Background/Purpose: Recent research suggests that multidimensional area-level indicators, including the Social Vulnerability Index (SVI), Area Deprivation Index (ADI) and Childhood Opportunity Index (COI), associate with childhood-onset systemic lupus erythematosus (cSLE) outcomes in primarily urban populations. However, to date, there are no studies that have assessed the utility of multidimensional area level indicators in children with cSLE living in rural areas. The goal of this study is to estimate relationships between neighborhood conditions and disease activity in children with cSLE who live in a mixed rural and urban setting. We hypothesized that patients with cSLE living in areas with higher social vulnerability and area-level deprivation have increased lupus activity.

Methods: We retrospectively evaluated electronic health record data for pediatric patients with cSLE across three pediatric rheumatology clinics at a single center between January 1, 2020 and December 31, 2024. We included patients with a diagnosis of cSLE before 18 years of age, a residential address within South Carolina, and excluded PO box addresses. Chart reviews were conducted to collect demographic data and addresses were linked to census tract-level indicators, including ADI, SVI and COI, ranked at state and national levels. We assessed each patient’s SLEDAI-2K score at their first clinic or hospital encounter associated with a SLE diagnosis.

Results: Baseline characteristics have been established for a cohort of 85 children with cSLE. The majority of patients identified as Black 65 (79%), followed by White 11 (13%), Latino/a 6 (6%), Asian 1 (1%), and Other 1 (1%). The cohort was predominantly female (87.1%), with a mean age at diagnosis of 13.0 years (range: 6–17). The mean SLEDAI-2K at the initial encounter was 14.4 (range: 0-38).  There was no statistically significant relationship found between any of the MDIs at the state level (AVI, SVI, and COI) and lupus disease activity, as evidenced by initial SLEDAI-2K score and attainment of LLDAS by the end of the study period. There was no relationship between state level AVI, SVI and COI on development of lupus nephritis and there was no relationship between state level AVI and SVI on development of CNS lupus. However, patients in high COI areas had lower odds of developing CNS lupus.

Conclusion: Most participants included in the cohort, lived in areas with low state ranked SVI scores, high deprivation scores and low opportunity. Despite the cohort’s residence in predominantly deprived and low-opportunity areas, these indicators did not appear to predict lupus severity at first presentation to care or development of complications from lupus. No significant association between any of the MDI’s at the state level (AVI, SVI and COI) and the SLEDAI-2K score or achieved of LLDAS during the study period was found. The study also found no significant association between the MDIs at the state level (AVI, SVI and COI) on complications of lupus, specifically lupus nephritis, however, the study did show that patients in high COI areas had lower odds of developing CNS lupus. 
 

Map 1 Supporting image 1Counties in SC included in cohort

Table 1 Supporting image 2Demographics of cohort

Table 2Supporting image 3Disease characteristics of cSLE cohort


Disclosures: C. Reynolds: None; N. Ruth: None; J. Chang: Century Therapeutics, 2.

To cite this abstract in AMA style:

Reynolds C, Ruth N, Chang J. Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/assessing-the-relationship-between-multidimensional-area-level-indicators-and-lupus-disease-activity-in-children-2/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-relationship-between-multidimensional-area-level-indicators-and-lupus-disease-activity-in-children-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology